Stock DECCAN DECCAN HEALTH CARE LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Deccan Health Care Limited

Equities

DECCAN

INE452W01019

Pharmaceuticals

Market Closed - Bombay S.E.
Other stock markets
 06:19:06 2024-05-27 am EDT 		5-day change 1st Jan Change
23.18 INR -6.04% Intraday chart for Deccan Health Care Limited +3.53% -27.59%
Feb. 12 Deccan Health Care Forms New Subsidiary in US MT
Feb. 06 Deccan Health Care Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI

Valuation

Fiscal Period: March 2019 2020 2021 2022 2023
Capitalization 1 1,682 431.3 462 561.8 468.7
Enterprise Value (EV) 1 1,666 409.8 440.1 547.6 468.5
P/E ratio 10.4 x 4.28 x 118 x 174 x 127 x
Yield - - - - -
Capitalization / Revenue 3.8 x 1.02 x 1.37 x 1.69 x 1.04 x
EV / Revenue 3.77 x 0.97 x 1.3 x 1.65 x 1.04 x
EV / EBITDA 9.91 x 3.51 x 21.3 x 9.5 x 23 x
EV / FCF -21.1 x -11 x -2,981 x -233 x -8.06 x
FCF Yield -4.73% -9.11% -0.03% -0.43% -12.4%
Price to Book 2.54 x 0.57 x 0.6 x 0.73 x 0.57 x
Nbr of stocks (in thousands) 15,713 15,713 15,713 15,713 17,043
Reference price 2 107.0 27.45 29.40 35.75 27.50
Announcement Date 9/4/19 9/7/20 9/6/21 9/5/22 9/4/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 378.3 442.5 422.4 337.8 331.7 450.2
EBITDA 1 140.5 168.2 116.9 20.62 57.63 20.35
EBIT 1 127.7 155.3 102.7 5.96 42.91 6.074
Operating Margin 33.77% 35.1% 24.32% 1.76% 12.93% 1.35%
Earnings before Tax (EBT) 1 133.4 145.7 101.3 5.191 5.425 5.172
Net income 1 133.6 144.8 100.9 3.899 3.226 3.64
Net margin 35.32% 32.73% 23.88% 1.15% 0.97% 0.81%
EPS 2 10.26 10.29 6.420 0.2481 0.2053 0.2170
Free Cash Flow 1 -62.22 -78.82 -37.33 -0.1476 -2.348 -58.12
FCF margin -16.45% -17.81% -8.84% -0.04% -0.71% -12.91%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 9/4/19 9/4/19 9/7/20 9/6/21 9/5/22 9/4/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 106 - - - - -
Net Cash position 1 - 15.9 21.5 21.9 14.2 0.23
Leverage (Debt/EBITDA) 0.7534 x - - - - -
Free Cash Flow 1 -62.2 -78.8 -37.3 -0.15 -2.35 -58.1
ROE (net income / shareholders' equity) 34.5% 25.8% 14.2% 0.51% 0.42% 0.46%
ROA (Net income/ Total Assets) 12.4% 12.7% 7.3% 0.4% 2.93% 0.4%
Assets 1 1,081 1,144 1,381 969.7 110 899
Book Value Per Share 2 34.20 42.10 48.50 48.80 49.00 47.90
Cash Flow per Share 2 0.2300 2.850 2.190 2.050 1.700 0.8400
Capex 1 51.8 44.3 18.1 1.58 1.12 -
Capex / Sales 13.69% 10.02% 4.29% 0.47% 0.34% -
Announcement Date 9/4/19 9/4/19 9/7/20 9/6/21 9/5/22 9/4/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Generic Pharmaceuticals

1st Jan change Capi.
DECCAN HEALTH CARE LIMITED Stock Deccan Health Care Limited
-27.59% 6.05M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+16.40% 42.95B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+16.64% 21.38B
SANDOZ GROUP AG Stock Sandoz Group AG
+20.14% 15.05B
CIPLA LIMITED Stock Cipla Limited
+18.64% 14.45B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+53.58% 13.04B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-12.52% 6.72B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+11.64% 5.47B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. DECCAN Stock
  4. Financials Deccan Health Care Limited